Valentis, Inc. is a biopharmaceutical company that is applying proprietary synthetic gene delivery, gene regulation and PEGylation technologies to create novel therapeutic products based on genomic discoveries in the fields of cardiovascular disease, oncology, hematology and infectious diseases. 

http://www.vfsc.com
863A Mitten Road Burlingame, CA 94010
Phone: (650) 697-1900Fax: (650) 652-1990